Skip to main content
. 2020 Oct 9;10:16945. doi: 10.1038/s41598-020-73787-6

Figure 1.

Figure 1

Overall analysis process. (A) Identification of potential cancer-cell-extrinsic lncRNAs through analysis of bulk RNA-sequencing data from the BCCRC- and TCGA-LUAD cohorts. (B) Exploration of lncRNA expression in single-cell RNA sequencing data of immune cells isolated from lung tumour samples (E-MTAB-6149). (C) Analysis of lncRNA expression in healthy human immune cells (GSE60424). (D) Assessment of lncRNA-based anti-tumour activity in vitro through both immune activation and siRNA-based assays.